2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.
| Autor: | Jaipuria, Jiten1, Jain, Ankita2, Gupta, Shashikant2, Sadasukhi, Nripesh2, Kasaraneni, Priyatham2, Singh, Amitabh2, Gupta, Kush3, Sharma, Girish1, Talwar, Vineet4, Rawal, Sudhir Kumar2 sudhirrawal85@gmail.com |
|---|---|
| Zdroj: | Indian Journal of Cancer. Oct-Dec2023, Vol. 60 Issue 4, p493-500. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|